Defining Value: The Payer Perspective
How a broader “value” understanding can benefit brand teams.
Marketing Curative Therapies: Are We Ready?
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
The Healing Art in Medicine
Pharm Exec talks with David Dosa, a leading physician in geriatric medicine, whose famous work with a cat named oscar in end-of-life diagnostics became the stuff of therapeutic legend.
CEO Snapshot: Steve Collis, Four Years Forward
A Pharm Exec conversation with AmerisourceBergen CEO Steve Collis
Pharma Caught in Political Crosshairs
Drug pricing backlash threatens regulatory reform, R&D advances
From the Editor: Demographic of Distress
A new discipline-population health-contests disease treatment as an end in itself. It asks: besides advancing the science of medicine, what do biopharmaceuticals actually do to improve health overall?
